ABPI
-
PMCPA resolves Moderna case regarding tweets, articles about clinical trials
Actions by Moderna and associated third parties caused concern and ‘reflected poorly on the industry’.
Actions by Moderna and associated third parties caused concern and ‘reflected poorly on the industry’.